Jessica Tassan
Stock Analyst at Piper Sandler
(0)
# 4279
Out of 5,253 analysts
84
Total ratings
28.57%
Success rate
-7.35%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Humana | Maintains: Neutral | 270 288 | 299.5 | -3.84% | 3 | Jan 15, 2025 | |
UnitedHealth Group | Maintains: Overweight | 605 600 | 540.12 | 11.09% | 5 | Jan 2, 2025 | |
Teladoc Health | Reiterates: Overweight | 11 13 | 10.53 | 23.46% | 5 | Dec 4, 2024 | |
Health Catalyst | Reiterates: Overweight | 11 12 | 5.7 | 110.53% | 10 | Nov 26, 2024 | |
CVS Health | Maintains: Overweight | 72 64 | 57.19 | 11.91% | 4 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 392 394 | 302.46 | 30.27% | 2 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 28 28 | 16.51 | 69.59% | 4 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 80 40 | 15.86 | 152.21% | 2 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 10 | 15.53 | -35.61% | 4 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 22 | 22.9 | -3.93% | 3 | May 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 12 15 | 6.89 | 117.71% | 4 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 21 23 | 56.67 | -59.41% | 3 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 | n/a | n/a | 3 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 43 40 | 27.86 | 43.58% | 4 | Sep 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 66 70 | 44.23 | 58.26% | 4 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 20 17 | n/a | n/a | 2 | May 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 50 100 | n/a | n/a | 6 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 100 70 | 10.26 | 582.26% | 2 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 47 39 | n/a | n/a | 2 | Feb 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 19 | n/a | n/a | 1 | Feb 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | n/a | n/a | 3 | Nov 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 40 33 | 10.49 | 214.59% | 2 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | n/a | n/a | 1 | Sep 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 34 31 | n/a | n/a | 2 | Sep 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 16 9 | n/a | n/a | 3 | Jun 23, 2022 |